Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p71
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 71/191)
Character Range: 10307655–10322409

neutropenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 6640
                                                                                                                                                                                                                               Patient must have an absolute neutrophil count of less than 500 million cells per litre lasting for 3 days per cycle, measured over 3 separate cycles; AND
                                                                                                                                                                                                                               Patient must have experienced a life-threatening infectious episode requiring hospitalisation and treatment with intravenous antibiotics.  or
                                                                                                                                                                                                                               Patient must have had at least 3 recurrent clinically significant infections in the previous 12 months.
C6643               P6643          CN6643           Ciclosporin                                                                                                                                                                Management of transplant rejection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 6643
                                                                                                                                                                                                                               Management (initiation, stabilisation and review of therapy)
                                                                                                                                                                                                                               Patient must have had an organ or tissue transplantation; AND
                                                                                                                                                                                                                               The treatment must be under the supervision and direction of a transplant unit.
C6647               P6647          CN6647           Mupirocin                                                                                                                                                                  Staphylococcus aureus infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 6647
                                                                                                                                                                                                                               Patient must have nasal colonisation with the bacteria;
                                                                                                                                                                                                                               Patient must be an Aboriginal or a Torres Strait Islander person.
C6653               P6653          CN6653           Filgrastim                                                                                                                                                                 Mobilisation of peripheral blood progenitor cells                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Compliance with Authority Required procedures - Streamlined Authority Code 6653
                                                                                                                                                                                                                               The treatment must be to facilitate harvest of peripheral blood progenitor cells for autologous transplantation into a patient with a non-myeloid malignancy who has had myeloablative or myelosuppressive therapy.
C6654               P6654          CN6654           Filgrastim                                                                                                                                                                 Mobilisation of peripheral blood progenitor cells                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Compliance with Authority Required procedures - Streamlined Authority Code 6654
                                                                                                                                                                                                                               The treatment must be in a normal volunteer for use in allogeneic transplantation.
C6655               P6655          CN6655           Filgrastim                                                                                                                                                                 Assisting autologous peripheral blood progenitor cell transplantation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Compliance with Authority Required procedures - Streamlined Authority Code 6655
                                                                                                                                                                                                                               The treatment must be following marrow-ablative chemotherapy for non-myeloid malignancy prior to the transplantation.
C6658               P6658          CN6658           Milk protein and fat formula with vitamins and minerals -- carbohydrate free                                                                                               Ketogenic diet
                                                                                                                                                                                                                               Patient must have intractable seizures requiring treatment with a ketogenic diet.  or
                                                    Soy protein and fat formula with vitamins and minerals -- carbohydrate free                                                                                                Patient must have a glucose transport protein defect.  or
                                                                                                                                                                                                                               Patient must have pyruvate dehydrogenase deficiency.  or
                                                                                                                                                                                                                               Patient must be an infant or young child with glucose-galactose intolerance and multiple monosaccharide intolerance.
C6660               P6660          CN6660           Ciclosporin                                                                                                                                                                Severe atopic dermatitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures - Streamlined Authority Code 6660
                                                                                                                                                                                                                               Management (initiation, stabilisation and review of therapy)
                                                                                                                                                                                                                               Must be treated by a dermatologist; or
                                                                                                                                                                                                                               Must be treated by a clinical immunologist; AND
                                                                                                                                                                                                                               The condition must be ineffective to other systemic therapies.  or
                                                                                                                                                                                                                               The condition must be inappropriate for other systemic therapies.
C6666               P6666          CN6666           Montelukast                                                                                                                                                                Asthma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 6666
                                                                                                                                                                                                                               First-line prevention
                                                                                                                                                                                                                               Patient must be aged 2 to 5 years inclusive;
                                                                                                                                                                                                                               The condition must be frequent intermittent; or
                                                                                                                                                                                                                               The condition must be mild persistent; AND
                                                                                                                                                                                                                               The treatment must be the single preventer agent; AND